TPWA
ANGO icon

Twin Peaks Wealth Advisors’s AngioDynamics ANGO Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$375 Buy
+33
New +$358 ﹤0.01% 2078

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Twin Peaks Wealth Advisors's ANGO Position: Q1 2026 in Review

Twin Peaks Wealth Advisors opened a new position in AngioDynamics (ANGO) in Q1 2026: 33 shares worth $375. The stake represents ﹤0.01% of the portfolio and ranks #2078 among its holdings.

147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Twin Peaks Wealth Advisors held 33 shares of AngioDynamics worth $375 as of Q1 2026.
  • AngioDynamics was a new Twin Peaks Wealth Advisors position in Q1 2026.
  • AngioDynamics made up ﹤0.01% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #2078 holding.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.